Clinical trial
Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
NCT00201630 · New York Prostate Institute, Other · Unknown status
Key facts
| NCT number | NCT00201630 |
|---|---|
| Title | Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy |
| Official title | Randomized, Open-Labeled Study of Prophylactic Vs. Therapeutic Use of Uroxatrol to Determine Improvements in Urinary Morbidity Following Men Undergoing Prostate Brachytherapy |
| Lead sponsor | New York Prostate Institute, Other |
| Collaborators | Sanofi Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Uroxatrol (drug) |
| Enrollment | 150 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 20, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: